|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/11 | |
| C12N 9/22 |
| (11) | Number of the document | 3280803 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16720220.9 |
| Date of filing the European patent application | 2016-04-05 | |
| (97) | Date of publication of the European application | 2018-02-14 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/026028 |
| Date | 2016-04-05 |
| (87) | Number | WO 2016/164356 |
| Date | 2016-10-13 |
| (30) | Number | Date | Country code |
| 201562143729 P | 2015-04-06 | US | |
| 201562160545 P | 2015-05-12 | US |
| (72) |
PORTEUS, Matthew H., US
HENDEL, Ayal, IL
CLARK, Joe, US
BAK, Rasmus O., DK
RYAN, Daniel E., US
DELLINGER, Douglas J., US
KAISER, Robert, US
MYERSON, Joel, US
|
| (73) |
Agilent Technologies, Inc.,
5301 Stevens Creek Blvd., Santa Clara, CA 95051,
US
The Board of Trustees of the Leland Stanford Junior University, Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, US |
| (54) | CHEMICALLY MODIFIED GUIDE RNAS FOR CRISPR/CAS-MEDIATED GENE REGULATION |
| CHEMICALLY MODIFIED GUIDE RNAS FOR CRISPR/CAS-MEDIATED GENE REGULATION |